CRP and COVID-19: To assess the impact of biomarkers on patients who either survived or succumbed to severe COVID-19, data from 322 samples were analyzed, including blood counts, C-reactive protein (CRP) (Table 1), and various inflammatory molecules (Table 2 and Table 3).